Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2010 by Center for Clinical Pharmacology Research Bdbeq S.A..
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
Laboratorio Elea S.A.C.I.F. y A.
Information provided by:
Center for Clinical Pharmacology Research Bdbeq S.A.
ClinicalTrials.gov Identifier:
NCT01227811
First received: October 18, 2010
Last updated: October 22, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)